Patou, Gary
47  Ergebnisse:
Personensuche X
?
 
?
3

Oral Octreotide Capsules Lowered Incidence and Improved Sev..:

Biermasz, Nienke ; Fleseriu, Maria ; Dreval, Akexander V...
Journal of the Endocrine Society.  5 (2021)  Supplement_1 - p. A522-A523 , 2021
 
?
4

A Phase 3 Large International Noninferiority Trial (MPOWERE..:

Fleseriu, Maria ; Dreval, Alexander V ; Pokramovich, Yulia...
Journal of the Endocrine Society.  5 (2021)  Supplement_1 - p. A517-A517 , 2021
 
?
5

One-Year Outcomes of the Open-Label Extension of CHIASMA OP..:

Samson, Susan Leanne ; Nachtigall, Lisa B ; Fleseriu, Maria...
Journal of the Endocrine Society.  5 (2021)  Supplement_1 - p. A515-A516 , 2021
 
?
6

Safety Results From MPOWERED, a Phase 3 Trial of Oral Octre..:

Freda, Pamela ; Fleseriu, Maria ; Dreval, Akexander V...
Journal of the Endocrine Society.  5 (2021)  Supplement_1 - p. A527-A528 , 2021
 
?
7

Improved Acromegaly Patient Satisfaction With Oral Octreoti..:

Gordon, Murray B ; Fleseriu, Maria ; Dreval, Akexander V...
Journal of the Endocrine Society.  5 (2021)  Supplement_1 - p. A520-A521 , 2021
 
?
8

Addition of Cabergoline to Oral Octreotide Capsules May Imp..:

Fleseriu, Maria ; Dreval, Akexander V ; Pokramovich, Yulia...
Journal of the Endocrine Society.  5 (2021)  Supplement_1 - p. A518-A519 , 2021
 
?
9

Maintenance of Acromegaly Control in Patients Switching Fro..:

Samson, Susan L ; Nachtigall, Lisa B ; Fleseriu, Maria...
The Journal of Clinical Endocrinology & Metabolism.  105 (2020)  10 - p. e3785-e3797 , 2020
 
1-15